Literature DB >> 11950396

Patient-evaluated outcome after surgery for basal meningiomas.

Ryojo Akagami1, Mario Napolitano, Laligam N Sekhar.   

Abstract

OBJECTIVE: To study the outcomes of patients with basal meningiomas treated by one primary surgeon with a philosophy of aggressive surgical management to establish an index of satisfaction and patient-evaluated outcome.
METHODS: We collected prospective data for patients with basal meningiomas who were operated on by one primary surgeon (LNS) during a 7-year period from 1993 to 2000. The outcomes in 269 patients were ascertained through follow-up visits, mailed follow-up questionnaires, and telephone interviews by two other surgeons (RA and MN). The mean patient age was 50 +/- 13.6 years. The mean estimated tumor diameter was 3.07 +/- 1.24 cm. There were 62 males and 207 females. Mean follow-up was 49 +/- 26 months. Twenty-seven percent of patients were Levine-Sekhar (LS) Grade 0, 43% were LS Grade I, 24% were LS Grade II, and 6% were LS Grade III. Gross total resection was achieved in 66% of patients. Extent of resection correlated (P < 0.05) with LS grade. Thirty-seven patients received adjuvant treatments, and six patients required reoperations. Perioperative mortality was 1.1%. Eighty percent of patients were discharged home, 17% were discharged to rehabilitation facilities, and 1.5% were discharged to nursing homes. Postoperative complications were observed in 30% of patients.
RESULTS: During the follow-up study, of a total of 269 patients, 30 patients could not be contacted, and 11 patients had died of unrelated causes. The mean follow-up Karnofsky Performance Scale score of the patients was 83 +/- 10. Ninety-seven percent of patients were very satisfied/satisfied with their treatments (P < 0.001). Forty-three percent of patients were employed, and 83% of patients were employable. Their expectations of treatment were met in 90% of patients (P < 0.001), 95% thought surgery had been a good treatment choice (P < 0.001), and 95% would recommend the same treatment for a family member (P < 0.001).
CONCLUSION: These results demonstrate that patient satisfaction can remain high and satisfactory outcome can be achieved with surgical management in patients with these complex lesions.

Entities:  

Mesh:

Year:  2002        PMID: 11950396     DOI: 10.1097/00006123-200205000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Levine-Sekhar grading system for prediction of the extent of resection of cranial base meningiomas revisited: study of 124 cases.

Authors:  Hooshang Saberi; Ali Tayebi Meybodi; Abdolreza Sheikh Rezai
Journal:  Neurosurg Rev       Date:  2006-01-11       Impact factor: 3.042

2.  Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas. Efficacy and safety after a follow-up of over 12 years.

Authors:  Mustafa El-Khatib; Faycal El Majdoub; Stefan Hunsche; Mauritius Hoevels; Martin Kocher; Volker Sturm; Mohammad Maarouf
Journal:  Strahlenther Onkol       Date:  2015-08-08       Impact factor: 3.621

Review 3.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

4.  Surgical Treatment of Meningiomas - Outcome Associated With Type of Resection, Recurrence, Karnofsky Performance Score, Mitotic Count.

Authors:  Robert Sumkovski; Micun Micunovic; Ivica Kocevski; Boro Ilievski; Igor Petrov
Journal:  Open Access Maced J Med Sci       Date:  2019-01-11

5.  Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study.

Authors:  Erik Thurin; Alba Corell; Sasha Gulati; Anja Smits; Roger Henriksson; J Bartek; Øyvind Salvesen; Asgeir Store Jakola
Journal:  Neurooncol Pract       Date:  2019-12-16

6.  Microsurgical treatment for parasagittal meningioma in the central gyrus region.

Authors:  Na Bi; Rui-Xue Xu; Rong-Yao Liu; Chun-Ming Wu; Jian Wang; Wei-Dong Chen; Jun Liu; You-Song Xu; Zhen-Qing Wei; Tao Li; Jian Zhang; Jing-Yang Bai; Bin Dong; Shu-Jun Fan; Ying-Hui Xu
Journal:  Oncol Lett       Date:  2013-06-26       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.